OpGen - Expanding presence in the Middle East
OpGen has announced plans to commercialize its Unyvero portfolio in the United Arab Emirates and Qatar through a new distribution agreement with Leader Life Sciences (LLS). This approach is similar to the company’s European roll-out, leveraging local networks to expand and strengthen Unyvero’s presence. Regulatory approval/product registration will be required in both markets before product launch, which will be initiated and managed by LLS. The three-year distribution agreement can be extended in annual increments and there is a minimum commitment for LLS to purchase at least eight Unyvero systems and unspecified numbers of cartridges (reflecting c $1m in transfer price-based revenues to OpGen).
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.